Showing results (31-40 of 379) with videos related to
Sort By:
Pageof 38
Journal of the American Society of Nephrology : JASN|August 20, 2016
Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic EffectsHiddo J L Heerspink, Mehul Desai, Meg Jardine, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 31, 2013
Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: systematic review and meta-analysis of randomized, controlled trialsAmanda Y Wang, Jessica N Ivany, Vlado Perkovic, et al.Transplantation|June 23, 2009
Cyclosporine withdrawal improves long-term graft survival in renal transplantationMartin Gallagher, Meg Jardine, Vlado Perkovic, et al.Cardiorenal Medicine|December 17, 2025
The Role of Inflammation and High-Sensitivity C-reactive Protein in Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease: the FLAME-ASCVD Survey Among NephrologistsVlado Perkovic, David Cherney, Edmundo Erazo-Tapia, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 9, 2012
Survival of elderly dialysis patients is predicted by both patient and practice characteristicsCeline Foote, Toshiharu Ninomiya, Martin Gallagher, et al.The Cochrane Database of Systematic Reviews|April 4, 2016
Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney diseaseYing Wang, Jessica N Ivany, Vlado Perkovic, et al.Kidney & Blood Pressure Research|April 17, 2003
Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cellsVlado Perkovic, Timothy D Hewitson, Kristen J Kelynack, et al.The Lancet. Diabetes & Endocrinology|March 25, 2016
Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysisJason H Y Wu, Celine Foote, Juuso Blomster, et al.Diabetes, Obesity & Metabolism|December 3, 2020
The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomesDaniel V O'Hara, Thomas R Parkhill, Sunil V Badve, et al.Clinical Kidney Journal|July 5, 2021
Effects of canagliflozin on serum potassium in the CANagliflozin cardioVascular Assessment Study (CANVAS) ProgramMatthew R Weir, April Slee, Tao Sun, et al.Pageof 38